208 related articles for article (PubMed ID: 11773625)
1. A fragment of human TrpRS as a potent antagonist of ocular angiogenesis.
Otani A; Slike BM; Dorrell MI; Hood J; Kinder K; Ewalt KL; Cheresh D; Schimmel P; Friedlander M
Proc Natl Acad Sci U S A; 2002 Jan; 99(1):178-83. PubMed ID: 11773625
[TBL] [Abstract][Full Text] [Related]
2. A human aminoacyl-tRNA synthetase as a regulator of angiogenesis.
Wakasugi K; Slike BM; Hood J; Otani A; Ewalt KL; Friedlander M; Cheresh DA; Schimmel P
Proc Natl Acad Sci U S A; 2002 Jan; 99(1):173-7. PubMed ID: 11773626
[TBL] [Abstract][Full Text] [Related]
3. T2-TrpRS inhibits preretinal neovascularization and enhances physiological vascular regrowth in OIR as assessed by a new method of quantification.
Banin E; Dorrell MI; Aguilar E; Ritter MR; Aderman CM; Smith AC; Friedlander J; Friedlander M
Invest Ophthalmol Vis Sci; 2006 May; 47(5):2125-34. PubMed ID: 16639024
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of tumor angiogenesis by a natural fragment of a tRNA synthetase.
Tzima E; Schimmel P
Trends Biochem Sci; 2006 Jan; 31(1):7-10. PubMed ID: 16297628
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of vascular endothelial growth factor-associated tyrosine kinase activity with SU5416 blocks sprouting in the microvascular endothelial cell spheroid model of angiogenesis.
Haspel HC; Scicli GM; McMahon G; Scicli AG
Microvasc Res; 2002 May; 63(3):304-15. PubMed ID: 11969307
[TBL] [Abstract][Full Text] [Related]
6. A short peptide insertion crucial for angiostatic activity of human tryptophanyl-tRNA synthetase.
Kise Y; Lee SW; Park SG; Fukai S; Sengoku T; Ishii R; Yokoyama S; Kim S; Nureki O
Nat Struct Mol Biol; 2004 Feb; 11(2):149-56. PubMed ID: 14730354
[TBL] [Abstract][Full Text] [Related]
7. VE-cadherin links tRNA synthetase cytokine to anti-angiogenic function.
Tzima E; Reader JS; Irani-Tehrani M; Ewalt KL; Schwartz MA; Schimmel P
J Biol Chem; 2005 Jan; 280(4):2405-8. PubMed ID: 15579907
[TBL] [Abstract][Full Text] [Related]
8. Biologically active fragment of a human tRNA synthetase inhibits fluid shear stress-activated responses of endothelial cells.
Tzima E; Reader JS; Irani-Tehrani M; Ewalt KL; Schwartz MA; Schimmel P
Proc Natl Acad Sci U S A; 2003 Dec; 100(25):14903-7. PubMed ID: 14630953
[TBL] [Abstract][Full Text] [Related]
9. Effect of mini-tyrosyl-tRNA synthetase/mini-tryptophanyl-tRNA synthetase on ischemic angiogenesis in rats: proliferation and migration of endothelial cells.
Zeng R; Chen YC; Zeng Z; Liu WQ; Jiang XF; Liu R; Qiang O; Li X
Heart Vessels; 2011 Jan; 26(1):69-80. PubMed ID: 20963594
[TBL] [Abstract][Full Text] [Related]
10. Oxidative stress-responsive intracellular regulation specific for the angiostatic form of human tryptophanyl-tRNA synthetase.
Wakasugi K; Nakano T; Morishima I
Biochemistry; 2005 Jan; 44(1):225-32. PubMed ID: 15628863
[TBL] [Abstract][Full Text] [Related]
11. Identification of a residue crucial for the angiostatic activity of human mini tryptophanyl-tRNA synthetase by focusing on its molecular evolution.
Nakamoto T; Miyanokoshi M; Tanaka T; Wakasugi K
Sci Rep; 2016 Apr; 6():24750. PubMed ID: 27094087
[TBL] [Abstract][Full Text] [Related]
12. AIDS-related Kaposi's sarcoma cells rapidly internalize endostatin, which co-localizes to tropomysin microfilaments and inhibits cytokine-mediated migration and invasion.
Mallery SR; Morse MA; Wilson RF; Pei P; Ness GM; Bradburn JE; Renner RJ; Schuller DE; Robertson FM
J Cell Biochem; 2003 May; 89(1):133-43. PubMed ID: 12682914
[TBL] [Abstract][Full Text] [Related]
13. Domain swapping in a COOH-terminal fragment of platelet factor 4 generates potent angiogenesis inhibitors.
Hagedorn M; Zilberberg L; Wilting J; Canron X; Carrabba G; Giussani C; Pluderi M; Bello L; Bikfalvi A
Cancer Res; 2002 Dec; 62(23):6884-90. PubMed ID: 12460903
[TBL] [Abstract][Full Text] [Related]
14. An alternative conformation of human TrpRS suggests a role of zinc in activating non-enzymatic function.
Xu X; Zhou H; Zhou Q; Hong F; Vo MN; Niu W; Wang Z; Xiong X; Nakamura K; Wakasugi K; Schimmel P; Yang XL
RNA Biol; 2018; 15(4-5):649-658. PubMed ID: 28910573
[TBL] [Abstract][Full Text] [Related]
15. Mapping and molecular characterization of novel monoclonal antibodies to conformational epitopes on NH2 and COOH termini of mammalian tryptophanyl-tRNA synthetase reveal link of the epitopes to aggregation and Alzheimer's disease.
Paley EL; Smelyanski L; Malinovskii V; Subbarayan PR; Berdichevsky Y; Posternak N; Gershoni JM; Sokolova O; Denisova G
Mol Immunol; 2007 Jan; 44(4):541-57. PubMed ID: 16616781
[TBL] [Abstract][Full Text] [Related]
16. Structural basis and potential role of heparin/heparan sulfate binding to the angiogenesis inhibitor endostatin.
Sasaki T; Larsson H; Kreuger J; Salmivirta M; Claesson-Welsh L; Lindahl U; Hohenester E; Timpl R
EMBO J; 1999 Nov; 18(22):6240-8. PubMed ID: 10562536
[TBL] [Abstract][Full Text] [Related]
17. PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration.
Wood JM; Bold G; Buchdunger E; Cozens R; Ferrari S; Frei J; Hofmann F; Mestan J; Mett H; O'Reilly T; Persohn E; Rösel J; Schnell C; Stover D; Theuer A; Towbin H; Wenger F; Woods-Cook K; Menrad A; Siemeister G; Schirner M; Thierauch KH; Schneider MR; Drevs J; Martiny-Baron G; Totzke F
Cancer Res; 2000 Apr; 60(8):2178-89. PubMed ID: 10786682
[TBL] [Abstract][Full Text] [Related]
18. A quantitative assay using basement membrane extracts to study tumor angiogenesis in vivo.
Ito Y; Iwamoto Y; Tanaka K; Okuyama K; Sugioka Y
Int J Cancer; 1996 Jul; 67(1):148-52. PubMed ID: 8690516
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of programmed cell death impairs in vitro vascular-like structure formation and reduces in vivo angiogenesis.
Segura I; Serrano A; De Buitrago GG; González MA; Abad JL; Clavería C; Gómez L; Bernad A; Martínez-A C; Riese HH
FASEB J; 2002 Jun; 16(8):833-41. PubMed ID: 12039865
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of angiogenesis by the cancer chemopreventive agent conjugated linoleic acid.
Masso-Welch PA; Zangani D; Ip C; Vaughan MM; Shoemaker S; Ramirez RA; Ip MM
Cancer Res; 2002 Aug; 62(15):4383-9. PubMed ID: 12154044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
